nodes	percent_of_prediction	percent_of_DWPC	metapath
Flupentixol—DDC—telencephalic ventricle—malignant glioma	0.0549	0.0986	CbGeAlD
Flupentixol—HTR2A—choroid plexus—malignant glioma	0.0537	0.0964	CbGeAlD
Flupentixol—DDC—pineal body—malignant glioma	0.0476	0.0855	CbGeAlD
Flupentixol—DRD1—telencephalic ventricle—malignant glioma	0.0404	0.0724	CbGeAlD
Flupentixol—HTR2A—cerebellar cortex—malignant glioma	0.027	0.0485	CbGeAlD
Flupentixol—DRD2—telencephalic ventricle—malignant glioma	0.0238	0.0428	CbGeAlD
Flupentixol—HTR2A—pons—malignant glioma	0.0191	0.0343	CbGeAlD
Flupentixol—HTR2A—vertebral column—malignant glioma	0.019	0.0341	CbGeAlD
Flupentixol—DDC—embryo—malignant glioma	0.0162	0.0291	CbGeAlD
Flupentixol—HTR2A—telencephalic ventricle—malignant glioma	0.0157	0.0282	CbGeAlD
Flupentixol—Trifluoperazine—CALY—malignant glioma	0.0152	0.712	CrCbGaD
Flupentixol—DDC—brainstem—malignant glioma	0.0149	0.0267	CbGeAlD
Flupentixol—HTR2A—pineal body—malignant glioma	0.0136	0.0245	CbGeAlD
Flupentixol—DDC—telencephalon—malignant glioma	0.0132	0.0237	CbGeAlD
Flupentixol—DRD1—brainstem—malignant glioma	0.0109	0.0196	CbGeAlD
Flupentixol—DRD1—telencephalon—malignant glioma	0.00969	0.0174	CbGeAlD
Flupentixol—DDC—midbrain—malignant glioma	0.00947	0.017	CbGeAlD
Flupentixol—HTR2A—endothelium—malignant glioma	0.00844	0.0152	CbGeAlD
Flupentixol—HTR2A—blood vessel—malignant glioma	0.00778	0.014	CbGeAlD
Flupentixol—DDC—central nervous system—malignant glioma	0.0075	0.0135	CbGeAlD
Flupentixol—CHRM1—telencephalon—malignant glioma	0.00711	0.0128	CbGeAlD
Flupentixol—DRD1—midbrain—malignant glioma	0.00696	0.0125	CbGeAlD
Flupentixol—ADRA1A—brainstem—malignant glioma	0.00658	0.0118	CbGeAlD
Flupentixol—DRD2—brainstem—malignant glioma	0.00645	0.0116	CbGeAlD
Flupentixol—DRD2—retina—malignant glioma	0.00622	0.0112	CbGeAlD
Flupentixol—DDC—brain—malignant glioma	0.00595	0.0107	CbGeAlD
Flupentixol—ADRA1A—telencephalon—malignant glioma	0.00584	0.0105	CbGeAlD
Flupentixol—DRD2—telencephalon—malignant glioma	0.00573	0.0103	CbGeAlD
Flupentixol—DRD1—central nervous system—malignant glioma	0.00551	0.00989	CbGeAlD
Flupentixol—ABCB1—blood vessel—malignant glioma	0.0051	0.00916	CbGeAlD
Flupentixol—HTR2A—embryo—malignant glioma	0.00464	0.00834	CbGeAlD
Flupentixol—DRD1—brain—malignant glioma	0.00437	0.00785	CbGeAlD
Flupentixol—HTR2A—brainstem—malignant glioma	0.00425	0.00764	CbGeAlD
Flupentixol—DRD2—midbrain—malignant glioma	0.00411	0.00738	CbGeAlD
Flupentixol—HTR2A—retina—malignant glioma	0.00411	0.00737	CbGeAlD
Flupentixol—CHRM1—central nervous system—malignant glioma	0.00404	0.00725	CbGeAlD
Flupentixol—HTR2A—telencephalon—malignant glioma	0.00378	0.00678	CbGeAlD
Flupentixol—Perphenazine—CYP2C18—malignant glioma	0.00353	0.165	CrCbGaD
Flupentixol—ADRA1A—central nervous system—malignant glioma	0.00332	0.00596	CbGeAlD
Flupentixol—DRD2—central nervous system—malignant glioma	0.00325	0.00584	CbGeAlD
Flupentixol—ADRA1A—cerebellum—malignant glioma	0.00324	0.00583	CbGeAlD
Flupentixol—CHRM1—brain—malignant glioma	0.00321	0.00576	CbGeAlD
Flupentixol—DRD2—cerebellum—malignant glioma	0.00318	0.00571	CbGeAlD
Flupentixol—ABCB1—embryo—malignant glioma	0.00304	0.00546	CbGeAlD
Flupentixol—HTR2A—medulla oblongata—malignant glioma	0.00297	0.00533	CbGeAlD
Flupentixol—HTR2A—midbrain—malignant glioma	0.00271	0.00487	CbGeAlD
Flupentixol—ABCB1—retina—malignant glioma	0.00269	0.00483	CbGeAlD
Flupentixol—HTR2A—spinal cord—malignant glioma	0.00265	0.00475	CbGeAlD
Flupentixol—ADRA1A—brain—malignant glioma	0.00264	0.00473	CbGeAlD
Flupentixol—Perphenazine—CYP2B6—malignant glioma	0.00262	0.123	CrCbGaD
Flupentixol—DRD2—brain—malignant glioma	0.00258	0.00464	CbGeAlD
Flupentixol—ABCB1—telencephalon—malignant glioma	0.00247	0.00444	CbGeAlD
Flupentixol—HTR2A—central nervous system—malignant glioma	0.00215	0.00385	CbGeAlD
Flupentixol—HTR2A—cerebellum—malignant glioma	0.0021	0.00377	CbGeAlD
Flupentixol—ABCB1—medulla oblongata—malignant glioma	0.00194	0.00349	CbGeAlD
Flupentixol—ABCB1—midbrain—malignant glioma	0.00178	0.00319	CbGeAlD
Flupentixol—ABCB1—spinal cord—malignant glioma	0.00173	0.00311	CbGeAlD
Flupentixol—HTR2A—brain—malignant glioma	0.0017	0.00306	CbGeAlD
Flupentixol—ABCB1—central nervous system—malignant glioma	0.00141	0.00253	CbGeAlD
Flupentixol—ABCB1—cerebellum—malignant glioma	0.00137	0.00247	CbGeAlD
Flupentixol—ABCB1—brain—malignant glioma	0.00112	0.002	CbGeAlD
Flupentixol—HTR2A—Signaling Pathways—HES1—malignant glioma	6.99e-05	0.000166	CbGpPWpGaD
Flupentixol—DRD2—Signaling by GPCR—RAF1—malignant glioma	6.97e-05	0.000165	CbGpPWpGaD
Flupentixol—ADRA1A—Signaling Pathways—PTK2—malignant glioma	6.96e-05	0.000165	CbGpPWpGaD
Flupentixol—DRD1—Signaling Pathways—CD80—malignant glioma	6.96e-05	0.000165	CbGpPWpGaD
Flupentixol—CHRM1—Signaling Pathways—HES1—malignant glioma	6.95e-05	0.000165	CbGpPWpGaD
Flupentixol—HTR2A—Signaling Pathways—NCOR1—malignant glioma	6.95e-05	0.000165	CbGpPWpGaD
Flupentixol—DRD1—Signaling Pathways—PIK3CG—malignant glioma	6.94e-05	0.000165	CbGpPWpGaD
Flupentixol—DRD1—Signaling Pathways—APC—malignant glioma	6.94e-05	0.000165	CbGpPWpGaD
Flupentixol—ADRA1A—GPCR downstream signaling—CXCL8—malignant glioma	6.93e-05	0.000164	CbGpPWpGaD
Flupentixol—CHRM1—Signaling Pathways—NCOR1—malignant glioma	6.91e-05	0.000164	CbGpPWpGaD
Flupentixol—DRD2—GPCR downstream signaling—IL2—malignant glioma	6.88e-05	0.000163	CbGpPWpGaD
Flupentixol—DRD1—Signaling Pathways—EGF—malignant glioma	6.86e-05	0.000163	CbGpPWpGaD
Flupentixol—HTR2A—Signaling by GPCR—RAF1—malignant glioma	6.85e-05	0.000163	CbGpPWpGaD
Flupentixol—ADRA1A—Signaling Pathways—HES1—malignant glioma	6.84e-05	0.000162	CbGpPWpGaD
Flupentixol—DRD1—Signaling Pathways—PTPN11—malignant glioma	6.82e-05	0.000162	CbGpPWpGaD
Flupentixol—CHRM1—Signaling by GPCR—RAF1—malignant glioma	6.82e-05	0.000162	CbGpPWpGaD
Flupentixol—ADRA1A—Signaling Pathways—NCOR1—malignant glioma	6.8e-05	0.000161	CbGpPWpGaD
Flupentixol—DRD2—Signaling by GPCR—PIK3CB—malignant glioma	6.8e-05	0.000161	CbGpPWpGaD
Flupentixol—HTR2A—GPCR downstream signaling—IL2—malignant glioma	6.77e-05	0.00016	CbGpPWpGaD
Flupentixol—DRD2—Signaling Pathways—PDGFRA—malignant glioma	6.76e-05	0.00016	CbGpPWpGaD
Flupentixol—CHRM1—GPCR downstream signaling—IL2—malignant glioma	6.73e-05	0.00016	CbGpPWpGaD
Flupentixol—ADRA1A—Signaling by GPCR—RAF1—malignant glioma	6.71e-05	0.000159	CbGpPWpGaD
Flupentixol—HTR2A—Signaling by GPCR—PIK3CB—malignant glioma	6.69e-05	0.000159	CbGpPWpGaD
Flupentixol—CHRM1—Signaling by GPCR—PIK3CB—malignant glioma	6.66e-05	0.000158	CbGpPWpGaD
Flupentixol—HTR2A—Signaling Pathways—PDGFRA—malignant glioma	6.65e-05	0.000158	CbGpPWpGaD
Flupentixol—ADRA1A—GPCR downstream signaling—IL2—malignant glioma	6.63e-05	0.000157	CbGpPWpGaD
Flupentixol—CHRM1—Signaling Pathways—PDGFRA—malignant glioma	6.62e-05	0.000157	CbGpPWpGaD
Flupentixol—DRD2—Signaling Pathways—SPP1—malignant glioma	6.56e-05	0.000156	CbGpPWpGaD
Flupentixol—ADRA1A—Signaling by GPCR—PIK3CB—malignant glioma	6.55e-05	0.000155	CbGpPWpGaD
Flupentixol—DRD2—Signaling by GPCR—CXCL8—malignant glioma	6.53e-05	0.000155	CbGpPWpGaD
Flupentixol—DRD1—Signaling Pathways—BRAF—malignant glioma	6.53e-05	0.000155	CbGpPWpGaD
Flupentixol—ADRA1A—Signaling Pathways—PDGFRA—malignant glioma	6.51e-05	0.000154	CbGpPWpGaD
Flupentixol—ABCB1—Transmembrane transport of small molecules—RAF1—malignant glioma	6.5e-05	0.000154	CbGpPWpGaD
Flupentixol—HTR2A—Signaling Pathways—SPP1—malignant glioma	6.46e-05	0.000153	CbGpPWpGaD
Flupentixol—HTR2A—Signaling by GPCR—CXCL8—malignant glioma	6.43e-05	0.000152	CbGpPWpGaD
Flupentixol—CHRM1—Signaling Pathways—SPP1—malignant glioma	6.42e-05	0.000152	CbGpPWpGaD
Flupentixol—CHRM1—Signaling by GPCR—CXCL8—malignant glioma	6.4e-05	0.000152	CbGpPWpGaD
Flupentixol—DRD1—Signaling Pathways—AKT2—malignant glioma	6.35e-05	0.000151	CbGpPWpGaD
Flupentixol—DRD1—Signaling by GPCR—EGFR—malignant glioma	6.33e-05	0.00015	CbGpPWpGaD
Flupentixol—ADRA1A—Signaling Pathways—SPP1—malignant glioma	6.32e-05	0.00015	CbGpPWpGaD
Flupentixol—ADRA1A—Signaling by GPCR—CXCL8—malignant glioma	6.3e-05	0.000149	CbGpPWpGaD
Flupentixol—DRD2—Signaling by GPCR—IL2—malignant glioma	6.25e-05	0.000148	CbGpPWpGaD
Flupentixol—DRD2—Signaling Pathways—TERT—malignant glioma	6.22e-05	0.000148	CbGpPWpGaD
Flupentixol—HTR2A—Signaling by GPCR—IL2—malignant glioma	6.14e-05	0.000146	CbGpPWpGaD
Flupentixol—HTR2A—Signaling Pathways—TERT—malignant glioma	6.12e-05	0.000145	CbGpPWpGaD
Flupentixol—CHRM1—Signaling by GPCR—IL2—malignant glioma	6.11e-05	0.000145	CbGpPWpGaD
Flupentixol—DRD1—Signaling Pathways—PIK3CD—malignant glioma	6.1e-05	0.000145	CbGpPWpGaD
Flupentixol—CHRM1—Signaling Pathways—TERT—malignant glioma	6.09e-05	0.000144	CbGpPWpGaD
Flupentixol—DRD2—Signaling Pathways—PDGFB—malignant glioma	6.07e-05	0.000144	CbGpPWpGaD
Flupentixol—DDC—Metabolism—AKT1—malignant glioma	6.07e-05	0.000144	CbGpPWpGaD
Flupentixol—DRD1—GPCR downstream signaling—PIK3CA—malignant glioma	6.05e-05	0.000143	CbGpPWpGaD
Flupentixol—DRD2—Signaling Pathways—FGFR1—malignant glioma	6.04e-05	0.000143	CbGpPWpGaD
Flupentixol—ADRA1A—Signaling by GPCR—IL2—malignant glioma	6.02e-05	0.000143	CbGpPWpGaD
Flupentixol—ADRA1A—Signaling Pathways—TERT—malignant glioma	5.99e-05	0.000142	CbGpPWpGaD
Flupentixol—DRD1—Signaling by GPCR—KRAS—malignant glioma	5.98e-05	0.000142	CbGpPWpGaD
Flupentixol—HTR2A—Signaling Pathways—PDGFB—malignant glioma	5.98e-05	0.000142	CbGpPWpGaD
Flupentixol—DRD2—Signaling Pathways—HIF1A—malignant glioma	5.95e-05	0.000141	CbGpPWpGaD
Flupentixol—HTR2A—Signaling Pathways—FGFR1—malignant glioma	5.94e-05	0.000141	CbGpPWpGaD
Flupentixol—CHRM1—Signaling Pathways—PDGFB—malignant glioma	5.94e-05	0.000141	CbGpPWpGaD
Flupentixol—CHRM1—Signaling Pathways—FGFR1—malignant glioma	5.91e-05	0.00014	CbGpPWpGaD
Flupentixol—HTR2A—Signaling Pathways—HIF1A—malignant glioma	5.86e-05	0.000139	CbGpPWpGaD
Flupentixol—ADRA1A—Signaling Pathways—PDGFB—malignant glioma	5.85e-05	0.000139	CbGpPWpGaD
Flupentixol—DRD1—Signaling Pathways—FGF2—malignant glioma	5.84e-05	0.000139	CbGpPWpGaD
Flupentixol—CHRM1—Signaling Pathways—HIF1A—malignant glioma	5.82e-05	0.000138	CbGpPWpGaD
Flupentixol—ADRA1A—Signaling Pathways—FGFR1—malignant glioma	5.82e-05	0.000138	CbGpPWpGaD
Flupentixol—DRD2—Signaling Pathways—CAV1—malignant glioma	5.76e-05	0.000137	CbGpPWpGaD
Flupentixol—ADRA1A—Signaling Pathways—HIF1A—malignant glioma	5.73e-05	0.000136	CbGpPWpGaD
Flupentixol—DRD2—Signaling Pathways—KDR—malignant glioma	5.69e-05	0.000135	CbGpPWpGaD
Flupentixol—ABCB1—Metabolism—GSTP1—malignant glioma	5.69e-05	0.000135	CbGpPWpGaD
Flupentixol—HTR2A—Signaling Pathways—CAV1—malignant glioma	5.66e-05	0.000134	CbGpPWpGaD
Flupentixol—CHRM1—Signaling Pathways—CAV1—malignant glioma	5.63e-05	0.000134	CbGpPWpGaD
Flupentixol—HTR2A—Signaling Pathways—KDR—malignant glioma	5.6e-05	0.000133	CbGpPWpGaD
Flupentixol—CHRM1—Signaling Pathways—KDR—malignant glioma	5.57e-05	0.000132	CbGpPWpGaD
Flupentixol—ADRA1A—Signaling Pathways—CAV1—malignant glioma	5.55e-05	0.000132	CbGpPWpGaD
Flupentixol—ABCB1—Metabolism—CAT—malignant glioma	5.53e-05	0.000131	CbGpPWpGaD
Flupentixol—DRD1—Signaling by GPCR—PIK3CA—malignant glioma	5.49e-05	0.00013	CbGpPWpGaD
Flupentixol—ADRA1A—Signaling Pathways—KDR—malignant glioma	5.48e-05	0.00013	CbGpPWpGaD
Flupentixol—DRD2—Signaling Pathways—F2—malignant glioma	5.48e-05	0.00013	CbGpPWpGaD
Flupentixol—DRD2—Signaling Pathways—FN1—malignant glioma	5.48e-05	0.00013	CbGpPWpGaD
Flupentixol—DRD1—Signaling Pathways—MDM2—malignant glioma	5.47e-05	0.00013	CbGpPWpGaD
Flupentixol—DRD1—Signaling Pathways—RAF1—malignant glioma	5.45e-05	0.000129	CbGpPWpGaD
Flupentixol—DRD2—Signaling Pathways—BAD—malignant glioma	5.41e-05	0.000128	CbGpPWpGaD
Flupentixol—DRD1—Signaling Pathways—ERBB2—malignant glioma	5.39e-05	0.000128	CbGpPWpGaD
Flupentixol—HTR2A—Signaling Pathways—FN1—malignant glioma	5.39e-05	0.000128	CbGpPWpGaD
Flupentixol—HTR2A—Signaling Pathways—F2—malignant glioma	5.39e-05	0.000128	CbGpPWpGaD
Flupentixol—CHRM1—Signaling Pathways—F2—malignant glioma	5.36e-05	0.000127	CbGpPWpGaD
Flupentixol—CHRM1—Signaling Pathways—FN1—malignant glioma	5.36e-05	0.000127	CbGpPWpGaD
Flupentixol—DRD2—Signaling Pathways—NOTCH1—malignant glioma	5.36e-05	0.000127	CbGpPWpGaD
Flupentixol—HTR2A—Signaling Pathways—BAD—malignant glioma	5.33e-05	0.000126	CbGpPWpGaD
Flupentixol—DRD1—Signaling Pathways—PIK3CB—malignant glioma	5.32e-05	0.000126	CbGpPWpGaD
Flupentixol—CHRM1—Signaling Pathways—BAD—malignant glioma	5.3e-05	0.000126	CbGpPWpGaD
Flupentixol—ADRA1A—Signaling Pathways—FN1—malignant glioma	5.28e-05	0.000125	CbGpPWpGaD
Flupentixol—ADRA1A—Signaling Pathways—F2—malignant glioma	5.28e-05	0.000125	CbGpPWpGaD
Flupentixol—HTR2A—Signaling Pathways—NOTCH1—malignant glioma	5.27e-05	0.000125	CbGpPWpGaD
Flupentixol—DRD2—Signaling Pathways—CD80—malignant glioma	5.25e-05	0.000125	CbGpPWpGaD
Flupentixol—CHRM1—Signaling Pathways—NOTCH1—malignant glioma	5.25e-05	0.000124	CbGpPWpGaD
Flupentixol—DRD2—Signaling Pathways—APC—malignant glioma	5.24e-05	0.000124	CbGpPWpGaD
Flupentixol—DRD2—Signaling Pathways—PIK3CG—malignant glioma	5.24e-05	0.000124	CbGpPWpGaD
Flupentixol—ABCB1—Metabolism—NCOR1—malignant glioma	5.23e-05	0.000124	CbGpPWpGaD
Flupentixol—ADRA1A—Signaling Pathways—BAD—malignant glioma	5.22e-05	0.000124	CbGpPWpGaD
Flupentixol—DRD2—Signaling Pathways—EGF—malignant glioma	5.18e-05	0.000123	CbGpPWpGaD
Flupentixol—HTR2A—Signaling Pathways—CD80—malignant glioma	5.17e-05	0.000123	CbGpPWpGaD
Flupentixol—ADRA1A—Signaling Pathways—NOTCH1—malignant glioma	5.16e-05	0.000122	CbGpPWpGaD
Flupentixol—HTR2A—Signaling Pathways—APC—malignant glioma	5.16e-05	0.000122	CbGpPWpGaD
Flupentixol—HTR2A—Signaling Pathways—PIK3CG—malignant glioma	5.16e-05	0.000122	CbGpPWpGaD
Flupentixol—DRD2—Signaling Pathways—PTPN11—malignant glioma	5.15e-05	0.000122	CbGpPWpGaD
Flupentixol—CHRM1—Signaling Pathways—CD80—malignant glioma	5.14e-05	0.000122	CbGpPWpGaD
Flupentixol—CHRM1—Signaling Pathways—PIK3CG—malignant glioma	5.13e-05	0.000122	CbGpPWpGaD
Flupentixol—CHRM1—Signaling Pathways—APC—malignant glioma	5.13e-05	0.000122	CbGpPWpGaD
Flupentixol—DRD1—Signaling Pathways—CXCL8—malignant glioma	5.11e-05	0.000121	CbGpPWpGaD
Flupentixol—HTR2A—Signaling Pathways—EGF—malignant glioma	5.1e-05	0.000121	CbGpPWpGaD
Flupentixol—CHRM1—Signaling Pathways—EGF—malignant glioma	5.07e-05	0.00012	CbGpPWpGaD
Flupentixol—HTR2A—Signaling Pathways—PTPN11—malignant glioma	5.07e-05	0.00012	CbGpPWpGaD
Flupentixol—ADRA1A—Signaling Pathways—CD80—malignant glioma	5.06e-05	0.00012	CbGpPWpGaD
Flupentixol—ADRA1A—Signaling Pathways—APC—malignant glioma	5.05e-05	0.00012	CbGpPWpGaD
Flupentixol—ADRA1A—Signaling Pathways—PIK3CG—malignant glioma	5.05e-05	0.00012	CbGpPWpGaD
Flupentixol—CHRM1—Signaling Pathways—PTPN11—malignant glioma	5.04e-05	0.00012	CbGpPWpGaD
Flupentixol—ADRA1A—Signaling Pathways—EGF—malignant glioma	4.99e-05	0.000118	CbGpPWpGaD
Flupentixol—ADRA1A—Signaling Pathways—PTPN11—malignant glioma	4.96e-05	0.000118	CbGpPWpGaD
Flupentixol—DRD1—GPCR downstream signaling—AKT1—malignant glioma	4.94e-05	0.000117	CbGpPWpGaD
Flupentixol—DRD2—Signaling Pathways—BRAF—malignant glioma	4.93e-05	0.000117	CbGpPWpGaD
Flupentixol—DRD1—Signaling Pathways—CASP3—malignant glioma	4.89e-05	0.000116	CbGpPWpGaD
Flupentixol—DRD1—Signaling Pathways—IL2—malignant glioma	4.89e-05	0.000116	CbGpPWpGaD
Flupentixol—HTR2A—Signaling Pathways—BRAF—malignant glioma	4.85e-05	0.000115	CbGpPWpGaD
Flupentixol—CHRM1—Signaling Pathways—BRAF—malignant glioma	4.82e-05	0.000114	CbGpPWpGaD
Flupentixol—DRD2—Signaling Pathways—AKT2—malignant glioma	4.8e-05	0.000114	CbGpPWpGaD
Flupentixol—DRD2—Signaling by GPCR—EGFR—malignant glioma	4.78e-05	0.000113	CbGpPWpGaD
Flupentixol—ADRA1A—Signaling Pathways—BRAF—malignant glioma	4.75e-05	0.000113	CbGpPWpGaD
Flupentixol—HTR2A—Signaling Pathways—AKT2—malignant glioma	4.72e-05	0.000112	CbGpPWpGaD
Flupentixol—HTR2A—Signaling by GPCR—EGFR—malignant glioma	4.7e-05	0.000111	CbGpPWpGaD
Flupentixol—CHRM1—Signaling Pathways—AKT2—malignant glioma	4.69e-05	0.000111	CbGpPWpGaD
Flupentixol—CHRM1—Signaling by GPCR—EGFR—malignant glioma	4.67e-05	0.000111	CbGpPWpGaD
Flupentixol—DRD1—Signaling Pathways—MMP9—malignant glioma	4.62e-05	0.00011	CbGpPWpGaD
Flupentixol—ADRA1A—Signaling Pathways—AKT2—malignant glioma	4.62e-05	0.00011	CbGpPWpGaD
Flupentixol—DRD2—Signaling Pathways—PIK3CD—malignant glioma	4.61e-05	0.000109	CbGpPWpGaD
Flupentixol—ADRA1A—Signaling by GPCR—EGFR—malignant glioma	4.6e-05	0.000109	CbGpPWpGaD
Flupentixol—DRD1—Signaling Pathways—PTEN—malignant glioma	4.6e-05	0.000109	CbGpPWpGaD
Flupentixol—DRD2—GPCR downstream signaling—PIK3CA—malignant glioma	4.56e-05	0.000108	CbGpPWpGaD
Flupentixol—HTR2A—Signaling Pathways—PIK3CD—malignant glioma	4.53e-05	0.000108	CbGpPWpGaD
Flupentixol—DRD2—Signaling by GPCR—KRAS—malignant glioma	4.51e-05	0.000107	CbGpPWpGaD
Flupentixol—CHRM1—Signaling Pathways—PIK3CD—malignant glioma	4.51e-05	0.000107	CbGpPWpGaD
Flupentixol—HTR2A—GPCR downstream signaling—PIK3CA—malignant glioma	4.49e-05	0.000107	CbGpPWpGaD
Flupentixol—DRD1—Signaling by GPCR—AKT1—malignant glioma	4.49e-05	0.000106	CbGpPWpGaD
Flupentixol—CHRM1—GPCR downstream signaling—PIK3CA—malignant glioma	4.47e-05	0.000106	CbGpPWpGaD
Flupentixol—ADRA1A—Signaling Pathways—PIK3CD—malignant glioma	4.44e-05	0.000105	CbGpPWpGaD
Flupentixol—HTR2A—Signaling by GPCR—KRAS—malignant glioma	4.44e-05	0.000105	CbGpPWpGaD
Flupentixol—CHRM1—Signaling by GPCR—KRAS—malignant glioma	4.42e-05	0.000105	CbGpPWpGaD
Flupentixol—DRD2—Signaling Pathways—FGF2—malignant glioma	4.41e-05	0.000105	CbGpPWpGaD
Flupentixol—ADRA1A—GPCR downstream signaling—PIK3CA—malignant glioma	4.4e-05	0.000104	CbGpPWpGaD
Flupentixol—ADRA1A—Signaling by GPCR—KRAS—malignant glioma	4.35e-05	0.000103	CbGpPWpGaD
Flupentixol—HTR2A—Signaling Pathways—FGF2—malignant glioma	4.34e-05	0.000103	CbGpPWpGaD
Flupentixol—CHRM1—Signaling Pathways—FGF2—malignant glioma	4.32e-05	0.000102	CbGpPWpGaD
Flupentixol—ABCB1—Metabolism—CAV1—malignant glioma	4.26e-05	0.000101	CbGpPWpGaD
Flupentixol—ADRA1A—Signaling Pathways—FGF2—malignant glioma	4.25e-05	0.000101	CbGpPWpGaD
Flupentixol—DRD1—Signaling Pathways—VEGFA—malignant glioma	4.15e-05	9.85e-05	CbGpPWpGaD
Flupentixol—DRD2—Signaling by GPCR—PIK3CA—malignant glioma	4.15e-05	9.83e-05	CbGpPWpGaD
Flupentixol—DRD2—Signaling Pathways—MDM2—malignant glioma	4.13e-05	9.79e-05	CbGpPWpGaD
Flupentixol—DRD2—Signaling Pathways—RAF1—malignant glioma	4.11e-05	9.76e-05	CbGpPWpGaD
Flupentixol—DRD1—Signaling Pathways—STAT3—malignant glioma	4.11e-05	9.75e-05	CbGpPWpGaD
Flupentixol—HTR2A—Signaling by GPCR—PIK3CA—malignant glioma	4.08e-05	9.67e-05	CbGpPWpGaD
Flupentixol—DRD2—Signaling Pathways—ERBB2—malignant glioma	4.07e-05	9.65e-05	CbGpPWpGaD
Flupentixol—HTR2A—Signaling Pathways—MDM2—malignant glioma	4.06e-05	9.63e-05	CbGpPWpGaD
Flupentixol—CHRM1—Signaling by GPCR—PIK3CA—malignant glioma	4.06e-05	9.62e-05	CbGpPWpGaD
Flupentixol—HTR2A—Signaling Pathways—RAF1—malignant glioma	4.05e-05	9.6e-05	CbGpPWpGaD
Flupentixol—CHRM1—Signaling Pathways—MDM2—malignant glioma	4.04e-05	9.58e-05	CbGpPWpGaD
Flupentixol—CHRM1—Signaling Pathways—RAF1—malignant glioma	4.03e-05	9.55e-05	CbGpPWpGaD
Flupentixol—DRD2—Signaling Pathways—PIK3CB—malignant glioma	4.02e-05	9.53e-05	CbGpPWpGaD
Flupentixol—HTR2A—Signaling Pathways—ERBB2—malignant glioma	4.01e-05	9.5e-05	CbGpPWpGaD
Flupentixol—ADRA1A—Signaling by GPCR—PIK3CA—malignant glioma	3.99e-05	9.47e-05	CbGpPWpGaD
Flupentixol—CHRM1—Signaling Pathways—ERBB2—malignant glioma	3.98e-05	9.45e-05	CbGpPWpGaD
Flupentixol—ADRA1A—Signaling Pathways—MDM2—malignant glioma	3.98e-05	9.43e-05	CbGpPWpGaD
Flupentixol—ADRA1A—Signaling Pathways—RAF1—malignant glioma	3.96e-05	9.4e-05	CbGpPWpGaD
Flupentixol—HTR2A—Signaling Pathways—PIK3CB—malignant glioma	3.95e-05	9.37e-05	CbGpPWpGaD
Flupentixol—CHRM1—Signaling Pathways—PIK3CB—malignant glioma	3.93e-05	9.32e-05	CbGpPWpGaD
Flupentixol—ADRA1A—Signaling Pathways—ERBB2—malignant glioma	3.92e-05	9.3e-05	CbGpPWpGaD
Flupentixol—ABCB1—Metabolism—PIK3CG—malignant glioma	3.88e-05	9.2e-05	CbGpPWpGaD
Flupentixol—ADRA1A—Signaling Pathways—PIK3CB—malignant glioma	3.87e-05	9.18e-05	CbGpPWpGaD
Flupentixol—DRD2—Signaling Pathways—CXCL8—malignant glioma	3.86e-05	9.16e-05	CbGpPWpGaD
Flupentixol—DRD1—Signaling Pathways—MYC—malignant glioma	3.82e-05	9.06e-05	CbGpPWpGaD
Flupentixol—HTR2A—Signaling Pathways—CXCL8—malignant glioma	3.8e-05	9.01e-05	CbGpPWpGaD
Flupentixol—CHRM1—Signaling Pathways—CXCL8—malignant glioma	3.78e-05	8.96e-05	CbGpPWpGaD
Flupentixol—ABCB1—Metabolism—PPARG—malignant glioma	3.75e-05	8.88e-05	CbGpPWpGaD
Flupentixol—DRD1—Signaling Pathways—EGFR—malignant glioma	3.74e-05	8.86e-05	CbGpPWpGaD
Flupentixol—DRD2—GPCR downstream signaling—AKT1—malignant glioma	3.73e-05	8.84e-05	CbGpPWpGaD
Flupentixol—ADRA1A—Signaling Pathways—CXCL8—malignant glioma	3.72e-05	8.82e-05	CbGpPWpGaD
Flupentixol—DRD2—Signaling Pathways—CASP3—malignant glioma	3.69e-05	8.76e-05	CbGpPWpGaD
Flupentixol—DRD2—Signaling Pathways—IL2—malignant glioma	3.69e-05	8.75e-05	CbGpPWpGaD
Flupentixol—HTR2A—GPCR downstream signaling—AKT1—malignant glioma	3.67e-05	8.7e-05	CbGpPWpGaD
Flupentixol—CHRM1—GPCR downstream signaling—AKT1—malignant glioma	3.65e-05	8.66e-05	CbGpPWpGaD
Flupentixol—HTR2A—Signaling Pathways—CASP3—malignant glioma	3.64e-05	8.62e-05	CbGpPWpGaD
Flupentixol—HTR2A—Signaling Pathways—IL2—malignant glioma	3.63e-05	8.61e-05	CbGpPWpGaD
Flupentixol—CHRM1—Signaling Pathways—CASP3—malignant glioma	3.62e-05	8.58e-05	CbGpPWpGaD
Flupentixol—CHRM1—Signaling Pathways—IL2—malignant glioma	3.61e-05	8.56e-05	CbGpPWpGaD
Flupentixol—ADRA1A—GPCR downstream signaling—AKT1—malignant glioma	3.59e-05	8.52e-05	CbGpPWpGaD
Flupentixol—ADRA1A—Signaling Pathways—CASP3—malignant glioma	3.56e-05	8.44e-05	CbGpPWpGaD
Flupentixol—ADRA1A—Signaling Pathways—IL2—malignant glioma	3.55e-05	8.43e-05	CbGpPWpGaD
Flupentixol—DRD1—Signaling Pathways—KRAS—malignant glioma	3.53e-05	8.37e-05	CbGpPWpGaD
Flupentixol—DRD2—Signaling Pathways—MMP9—malignant glioma	3.49e-05	8.28e-05	CbGpPWpGaD
Flupentixol—DRD2—Signaling Pathways—PTEN—malignant glioma	3.47e-05	8.23e-05	CbGpPWpGaD
Flupentixol—HTR2A—Signaling Pathways—MMP9—malignant glioma	3.44e-05	8.15e-05	CbGpPWpGaD
Flupentixol—CHRM1—Signaling Pathways—MMP9—malignant glioma	3.42e-05	8.1e-05	CbGpPWpGaD
Flupentixol—HTR2A—Signaling Pathways—PTEN—malignant glioma	3.42e-05	8.1e-05	CbGpPWpGaD
Flupentixol—ABCB1—Metabolism—PIK3CD—malignant glioma	3.41e-05	8.09e-05	CbGpPWpGaD
Flupentixol—CHRM1—Signaling Pathways—PTEN—malignant glioma	3.4e-05	8.06e-05	CbGpPWpGaD
Flupentixol—DRD2—Signaling by GPCR—AKT1—malignant glioma	3.39e-05	8.03e-05	CbGpPWpGaD
Flupentixol—ADRA1A—Signaling Pathways—MMP9—malignant glioma	3.36e-05	7.98e-05	CbGpPWpGaD
Flupentixol—ADRA1A—Signaling Pathways—PTEN—malignant glioma	3.34e-05	7.93e-05	CbGpPWpGaD
Flupentixol—HTR2A—Signaling by GPCR—AKT1—malignant glioma	3.33e-05	7.9e-05	CbGpPWpGaD
Flupentixol—CHRM1—Signaling by GPCR—AKT1—malignant glioma	3.31e-05	7.86e-05	CbGpPWpGaD
Flupentixol—ADRA1A—Signaling by GPCR—AKT1—malignant glioma	3.26e-05	7.74e-05	CbGpPWpGaD
Flupentixol—DRD1—Signaling Pathways—PIK3CA—malignant glioma	3.24e-05	7.69e-05	CbGpPWpGaD
Flupentixol—DRD1—Signaling Pathways—TP53—malignant glioma	3.14e-05	7.44e-05	CbGpPWpGaD
Flupentixol—DRD2—Signaling Pathways—VEGFA—malignant glioma	3.14e-05	7.44e-05	CbGpPWpGaD
Flupentixol—DRD2—Signaling Pathways—STAT3—malignant glioma	3.1e-05	7.36e-05	CbGpPWpGaD
Flupentixol—HTR2A—Signaling Pathways—VEGFA—malignant glioma	3.08e-05	7.32e-05	CbGpPWpGaD
Flupentixol—CHRM1—Signaling Pathways—VEGFA—malignant glioma	3.07e-05	7.28e-05	CbGpPWpGaD
Flupentixol—HTR2A—Signaling Pathways—STAT3—malignant glioma	3.05e-05	7.24e-05	CbGpPWpGaD
Flupentixol—CHRM1—Signaling Pathways—STAT3—malignant glioma	3.04e-05	7.21e-05	CbGpPWpGaD
Flupentixol—ADRA1A—Signaling Pathways—VEGFA—malignant glioma	3.02e-05	7.16e-05	CbGpPWpGaD
Flupentixol—ADRA1A—Signaling Pathways—STAT3—malignant glioma	2.99e-05	7.09e-05	CbGpPWpGaD
Flupentixol—ABCB1—Metabolism—PIK3CB—malignant glioma	2.97e-05	7.05e-05	CbGpPWpGaD
Flupentixol—ABCB1—Metabolism—PTGS2—malignant glioma	2.95e-05	6.99e-05	CbGpPWpGaD
Flupentixol—DRD2—Signaling Pathways—MYC—malignant glioma	2.88e-05	6.84e-05	CbGpPWpGaD
Flupentixol—HTR2A—Signaling Pathways—MYC—malignant glioma	2.84e-05	6.73e-05	CbGpPWpGaD
Flupentixol—CHRM1—Signaling Pathways—MYC—malignant glioma	2.82e-05	6.7e-05	CbGpPWpGaD
Flupentixol—DRD2—Signaling Pathways—EGFR—malignant glioma	2.82e-05	6.69e-05	CbGpPWpGaD
Flupentixol—ADRA1A—Signaling Pathways—MYC—malignant glioma	2.78e-05	6.59e-05	CbGpPWpGaD
Flupentixol—HTR2A—Signaling Pathways—EGFR—malignant glioma	2.78e-05	6.58e-05	CbGpPWpGaD
Flupentixol—CHRM1—Signaling Pathways—EGFR—malignant glioma	2.76e-05	6.55e-05	CbGpPWpGaD
Flupentixol—ADRA1A—Signaling Pathways—EGFR—malignant glioma	2.72e-05	6.45e-05	CbGpPWpGaD
Flupentixol—DRD2—Signaling Pathways—KRAS—malignant glioma	2.67e-05	6.32e-05	CbGpPWpGaD
Flupentixol—DRD1—Signaling Pathways—AKT1—malignant glioma	2.65e-05	6.28e-05	CbGpPWpGaD
Flupentixol—HTR2A—Signaling Pathways—KRAS—malignant glioma	2.62e-05	6.22e-05	CbGpPWpGaD
Flupentixol—CHRM1—Signaling Pathways—KRAS—malignant glioma	2.61e-05	6.19e-05	CbGpPWpGaD
Flupentixol—ABCB1—Metabolism—PTEN—malignant glioma	2.57e-05	6.09e-05	CbGpPWpGaD
Flupentixol—ADRA1A—Signaling Pathways—KRAS—malignant glioma	2.57e-05	6.09e-05	CbGpPWpGaD
Flupentixol—DRD2—Signaling Pathways—PIK3CA—malignant glioma	2.45e-05	5.81e-05	CbGpPWpGaD
Flupentixol—HTR2A—Signaling Pathways—PIK3CA—malignant glioma	2.41e-05	5.71e-05	CbGpPWpGaD
Flupentixol—CHRM1—Signaling Pathways—PIK3CA—malignant glioma	2.4e-05	5.68e-05	CbGpPWpGaD
Flupentixol—DRD2—Signaling Pathways—TP53—malignant glioma	2.37e-05	5.62e-05	CbGpPWpGaD
Flupentixol—ADRA1A—Signaling Pathways—PIK3CA—malignant glioma	2.36e-05	5.6e-05	CbGpPWpGaD
Flupentixol—HTR2A—Signaling Pathways—TP53—malignant glioma	2.33e-05	5.53e-05	CbGpPWpGaD
Flupentixol—CHRM1—Signaling Pathways—TP53—malignant glioma	2.32e-05	5.5e-05	CbGpPWpGaD
Flupentixol—ADRA1A—Signaling Pathways—TP53—malignant glioma	2.28e-05	5.41e-05	CbGpPWpGaD
Flupentixol—DRD2—Signaling Pathways—AKT1—malignant glioma	2e-05	4.74e-05	CbGpPWpGaD
Flupentixol—HTR2A—Signaling Pathways—AKT1—malignant glioma	1.97e-05	4.67e-05	CbGpPWpGaD
Flupentixol—CHRM1—Signaling Pathways—AKT1—malignant glioma	1.96e-05	4.64e-05	CbGpPWpGaD
Flupentixol—ADRA1A—Signaling Pathways—AKT1—malignant glioma	1.93e-05	4.57e-05	CbGpPWpGaD
Flupentixol—ABCB1—Metabolism—PIK3CA—malignant glioma	1.81e-05	4.3e-05	CbGpPWpGaD
Flupentixol—ABCB1—Metabolism—AKT1—malignant glioma	1.48e-05	3.51e-05	CbGpPWpGaD
